For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Medtronic Plc’s stock clocked out at $96.42, down -0.55% from its previous closing price of $96.95. In other words, the price has decreased by -$0.55 from its previous closing price. On the day, 5.78 million shares were traded. MDT stock price reached its highest trading level at $97.315 during the session, while it also had its lowest trading level at $95.93.
Ratios:
To gain a deeper understanding of MDT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.74. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.57.
On November 19, 2025, Goldman Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $111.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’25 when Smith Gregory L sold 30,000 shares for $101.95 per share. The transaction valued at 3,058,451 led to the insider holds 46,016 shares of the business.
Smith Gregory L bought 30,000 shares of MDT for $3,058,452 on Nov 19 ’25. On Sep 03 ’25, another insider, KIIL HARRY SKIP, who serves as the EVP & President Cardiovascular of the company, sold 8,605 shares for $91.58 each. As a result, the insider received 788,048 and left with 35,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDT now has a Market Capitalization of 123669839872 and an Enterprise Value of 144588816384. As of this moment, Medtronic’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.05, and their Forward P/E ratio for the next fiscal year is 15.75. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.56 while its Price-to-Book (P/B) ratio in mrq is 2.54. Its current Enterprise Value per Revenue stands at 4.16 whereas that against EBITDA is 15.104.
Stock Price History:
The Beta on a monthly basis for MDT is 0.72, which has changed by 0.13524592 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, MDT has reached a high of $106.33, while it has fallen to a 52-week low of $79.55. The 50-Day Moving Average of the stock is -1.64%, while the 200-Day Moving Average is calculated to be 5.27%.
Shares Statistics:
It appears that MDT traded 6.61M shares on average per day over the past three months and 5951400 shares per day over the past ten days. A total of 1.28B shares are outstanding, with a floating share count of 1.28B. Insiders hold about 0.08% of the company’s shares, while institutions hold 88.54% stake in the company. Shares short for MDT as of 1767139200 were 14397372 with a Short Ratio of 2.18, compared to 1764288000 on 18974699. Therefore, it implies a Short% of Shares Outstanding of 14397372 and a Short% of Float of 1.13.
Dividends & Splits
With its trailing 12-month dividend rate of 2.82, MDT has a forward annual dividend rate of 2.83. Against a Trailing Annual Dividend Yield of 0.029087158. The stock’s 5-year Average Dividend Yield is 2.89. The current Payout Ratio is 77.47% for MDT, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-12-26. Stock splits for the company last occurred on 1999-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
Currently, 22.0 analysts are dedicated to thoroughly evaluating and rating the performance of Medtronic Plc (MDT) in the stock market.The consensus estimate for the next quarter is $1.69, with high estimates of $1.7 and low estimates of $1.68.
Analysts are recommending an EPS of between $6.0 and $5.58 for the fiscal current year, implying an average EPS of $5.65. EPS for the following year is $6.11, with 27.0 analysts recommending between $6.25 and $5.98.
Revenue Estimates
In. The current quarter, 15 analysts expect revenue to total $8.89B. It ranges from a high estimate of $8.91B to a low estimate of $8.86B. As of. The current estimate, Medtronic Plc’s year-ago sales were $8.29BFor the next quarter, 15 analysts are estimating revenue of $9.64B. There is a high estimate of $9.68B for the next quarter, whereas the lowest estimate is $9.58B.
A total of 16 analysts have provided revenue estimates for MDT’s current fiscal year. The highest revenue estimate was $36.12B, while the lowest revenue estimate was $35.96B, resulting in an average revenue estimate of $36.05B. In the same quarter a year ago, actual revenue was $33.54BBased on 16 analysts’ estimates, the company’s revenue will be $38.09B in the next fiscal year. The high estimate is $38.62B and the low estimate is $37.82B.
